About Aceragen

Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.

Company Highlights
Year Founded

2021

icon-altStatus

Acquired

icon-altEmployees

5

Location (HQ)

USA

Since Last Funding

3 years 4 months

Monthly Website Visitors

1.5K

icon-altTotal Investment Amt

$35M

Last Funding Round

Private Equity

icon-altYoY Headcount Growth

-70.18%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Medical

Health Care

Biotechnology

Biotechnology Research

Pharmaceutical